Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Large hedge fund startups raise money easily but perform worst

Monday, July 18, 2011

From Precy Dumlao, Opalesque Asia:

Large hedge fund startups, usually with a minimum of $75m in assets under management (AuM) consistently underperform, yet it is easier for this hedge fund group to raise assets at a much higher rate compared with their smaller counterparts. This was the findings of GFIA, a Singapore-based research firm.

"Except for the very small launches, those with AUM of $5m or less on day one, and the large launches, those with AUM of more than $75m on day one, close to 80% of funds which liquidated, did so within five years from inception. The average lifespan was 3.9 years. Funds which launched with AUM of less than $5m showed low consistency in outperforming their peers, while funds which launched with an AUM of more than $75m consistently underperformed," the study said.

GFIA studied some 510 hedge funds from the Eurekahedge Emerging Market database with data going all the way back to January 2000. The research found that, over the past 11 years, close to 70% of hedge funds in Asia, excluding Japan and Australia, launched with an AUM of $25m or less. The average launch size of a fund over the same period was just $23m. No funds in the database launched with an AuM of more than $400m

Funds that launched with an AuM of between $10m and $25m tend to show the most consistent outperformance. Funds with an initial AUM of less than $5m have three-year returns that fluctuate the most, outperf......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for